Indian generic drugmaker Dr. Reddy's Laboratories Ltd posted an over seven-fold rise in first-quarter net profit on Thursday, handily beating market expectations, aided by the launch of a generic version of an opioid addiction drug.
Net profit came in at 4.76 billion rupees ($69.31 million) in the quarter ended June 30, compared with 666 million rupees a year earlier, the company said.
Analysts on average had expected a net profit of 2.98 billion rupees, according to estimates compiled by Thomson Reuters I/B/E/S.
First Published: Jul 26, 2018 3:29 PM IST